– UK, Sedgefield – Kromek Group (LON: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, today announced the appointment of Rakesh Sharma OBE to its Board as a Non-executive Director with immediate effect.
“I am delighted to welcome Rakesh to the Board of Kromek. Throughout a distinguished career in global technology and engineering businesses, Rakesh has successfully channelled innovation to deliver growth and create value. In particular, he brings significant experience in the security and defence sector, which is a key market for Kromek. We look forward to benefiting from his considerable expertise as we continue to advance our business.” said Board Chairman, Sir Peter Williams.
About Rakesh Sharma
Mr Sharma is a former FTSE 250 CEO with 20 years’ experience in running international hi-tech engineering and manufacturing businesses. He was instrumental in the growth of Ultra Electronics Holdings plc, the LSE-listed group that specialises in providing engineering solutions for mission-critical systems in the defence, security, critical detection and control markets. Having joined at its formation in 1993, Mr Sharma presided over significant revenue and profit growth across multiple director-level and divisional roles, including in North America, latterly serving for six years as CEO. He began his career in 1983 in the military radio division of Marconi Communication Systems Ltd. In 1989, he joined Dowty Group as a chief engineer before it was acquired by TI Group in 1992, which a year later became Ultra Electronics Holdings following a management buy-out.
Since 2017, Mr Sharma has sat on the Board of LSE-listed PayPoint plc, a provider of omnichannel payments solutions and EPoS-enabled technologies, where he serves as Senior Independent Director. He also supports a range of small businesses and entrepreneurs in a non-executive capacity. Mr Sharma was elected as a Fellow of the Royal Academy of Engineering in 2016 and was honoured in the 2017 Queen’s Birthday Honours List with an OBE for services to defence capability.
Rakesh Sharma OBE said: “I am delighted to be joining Kromek, a growing and ambitious company which is developing important products to help safeguard lives and property as well as, through early diagnosis, improve outcomes of people suffering from debilitating illnesses. I will bring my extensive experience in the security and defence sector to help and assist wherever I can. This is an exciting challenge for me personally and I look forward to working with the Board and making a real contribution to the success of this dynamic company.”
About Kromek Group plc
Kromek Group plc is a technology group and a leading developer of high-performance radiation detection products based on cadmium zinc telluride and other advanced technologies. Using its core technology platforms, Kromek designs develops and produces x-ray and gamma-ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group’s products provide high-resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group’s business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application-specific integrated circuits.
The Group has operations in the UK and US and is selling internationally through a combination of distributors and direct OEM sales.
For more information: https://www.kromek.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.